sathyabaarathi sr

Systems immunology | Aging | Computational Biology | Postdoctoral researcher @jacksonlab | PhD @iiscbangalore

[Atul Butte (In Memoriam) @atulbutte]

Today I learned at the @NIAID_news #AI symposium… PubMed Central has 9.9 million full text articles (https://t.co/ezhIEVZsd9)... and here's how to access each article via API in BioC XML format https://t.co/wPZixnLARt … even the tables are parsed out!

[Matt Mulè @MPMule]

Our paper "Integrating population and single-cell variations in vaccine responses identifies a naturally adjuvanted human immune setpoint" @TsangLab is now online @ImmunityCP Link to open access pdf: https://t.co/E8zXxQoI1l

[Amrisha Bhosle @AmrishaBhosle]

Excited to share the newest addition to the Huttenhower lab's (bio)bakery - MACARRoN, a tool for prioritization of phenotype-linked metabolites 😀

[Waggoner Lab @LabWaggoner]

Easily my favorite paper of 2024 so far (and of past year): https://t.co/qsx9QtMVNb @NatImmunol @sathyabaarathi @jacksonlab @FernandoErra @duyguucar Karakaşlar
Baseline predictors of Ab/plasmablast responses in vaccinated older adults differ with PPSV23 & PCV13 vaccines.

[Hesper Rego @Rego_Lab]

Really excited about this work from the lab. @celenagwin, together with @Kuldeep_R_Gupta, worked to understand how mycobacteria create heterogeneity in growth. https://t.co/OIHGHOn4pP

[Malcolm Sim @mjwsim]

Delighted that our paper 'Innate receptors with high specificity for HLA class I–peptide complexes' is now published in Science Immunology @SciImmunology

https://t.co/hkM3DQ01d9.

[Great Ormond Street Hospital for Children @GreatOrmondSt]

6 months ago, after all other treatments for T-cell acute lymphoblastic leukaemia had failed, Alyssa became the first person in the world to receive base-edited cell therapy as part of a clinical trial at GOSH & @UCLchildhealth. Meet Alyssa & the research team behind the trial 👇

[Amrisha Bhosle @AmrishaBhosle]

Congratulations @ycongzhang and team👏😁

[Prof. Akiko Iwasaki @VirusesImmunity]

We need your help for some crucial #LongCOVID research! If you live in the New York area, have FULLY recovered from COVID-19 infection and it has been AT LEAST 12 weeks since you were first sick, please email us at [email protected]  @PutrinoLab

RT highly appreciated 🙏🏼

[sathyabaarathi sr @sathyabaarathi]

@consiglio_cr @MichelsonMedRF @HumanVacProject @BrodinPetter Congrats @consiglio_cr

[Prof. Akiko Iwasaki @VirusesImmunity]

So excited to be a part of this important study led by @michelle_monje on how significant longterm neurologic damage can occur after a mild respiratory-only SARS-CoV-2 infection. My own🧵on the findings of this study with relevance to #longCovid (1/)

https://t.co/MgXZRrh899

[sathyabaarathi sr @sathyabaarathi]

Omicron thwarts some of the world’s most-used COVID vaccines https://t.co/BnXEiZYja6

[sathyabaarathi sr @sathyabaarathi]

Informative thread on #OmicronVariant

[Florian Krammer @florian_krammer]

1) My gut feeling from hearing of Omicron cases in Botswana, ex-Malawi, ex-Egypt (2 now it seems) and in South Africa is, that the variant was flying under the radar in undersequenced countries for some time until Botswana and South Africa detected it and sounded the alarm.

[bioRxiv @biorxivpreprint]

Combinatorial transcriptional codes specify macrophage polarization destinations https://t.co/rVvWOMP2JZ #bioRxiv

[bioRxiv SysBio @biorxiv_sysbio]

Combinatorial transcriptional codes specify macrophage polarization destinations https://t.co/grDBDCZIHN #biorxiv_sysbio

[Women in Statistics and Data Science @WomenInStat]

I am crazily obsessed with #reproducibility and good computing/datasci practices.
Who is with me? 👋

Today, let's all share resources on how to be more reproducible!

I'll start 🧵👇

[PeterK @KharchenkoLab]

Nature Methods was kind enough to give me an opportunity to revisit how scRNA-seq data is being analyzed, and consider why it is done in such a way. Much of it is an exercise in approximation. Tradeoffs and limitations abound.

[Purvesh Khatri @purveshkhatri]

Thrilled to have preprint of our systems immunology longitudinal analysis of Pfizer-BioNTech vaccine with Bali Pulendran, Kari Nadeau, PJ Utz, Mark Davis, Scott Boyd, Holden Maecker and many others out. https://t.co/cxv1RfcNwV

[sathyabaarathi sr @sathyabaarathi]

@awanti_sp @iiscbangalore Thanks @awanti_sp 😊

[IISc Bangalore @iiscbangalore]

In a new study, researchers from IISc have identified molecular biomarkers that can be used to detect and predict with high probability whether an infection is viral or bacterial
https://t.co/tJDih8LVyH